1d
Clinical Trials Arena on MSNViiV to trial twice-yearly HIV antibody dosing after Phase IIb successThe company’s Phase IIb trial found the therapy, N6LS, was able to maintain viral loads below a detectable threshold.
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced positive findings from the company’s EMBRACE phase IIb study.
moodle-mod_ivs is a Moodle activity plugin to allow Social Video Learning. Enrich your videos by the powerful features of the social video player. Create pinpointed video comments for real discussions ...
Opus IVS has partnered with Elitek Vehicle Services to release ADAS MAP, a tool to help shops properly diagnose, calibrate, and repair advanced driver assistance systems, according to a press release.
Mental health professionals no longer diagnose ADD. Instead, they diagnose one of three types of ADHD: inattentive, hyperactive-impulsive, or combined. Attention deficit hyperactivity disorder ...
We also completed the previously announced acquisition of Precision Coating and signed a definitive agreement to acquire VSi Parylene ... related costs; (iv) other general expenses; (v) (gain ...
The company announced the acquisition of Precision Coating for $152 million and VSI Paroline for $28 million, enhancing their vertical integration and proprietary coating capabilities. Integer ...
I got out of the Xfinity car, went and got IVs, and still felt like crap. I didn’t even race the sprint car because I felt that bad,” he added, elaborating on the levels of heat fatigue and ...
Guidance incorporates inorganic growth from Precision Coating and VSi Parylene acquisitions, partially offset by the divestiture of the Portable Medical product line. Q4 2024 adjusted EPS was $1. ...
Integer Holdings Corp (NYSE:ITGR) reported its fourth-quarter 2024 earnings, showcasing a strong performance with revenues reaching $449 million, surpassing expectations. Despite a slight miss in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results